MyFinsight
Home
Compare
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Show more
Subscribe for Financial Insights
Page 1
123
Page 1
Financial Ratios
2026-06-30
Free Cash flow
-12,919
Return on Equity
14.563
Net Profit Margin
-337.8
Debt to Asset Ratio
176.804
Cash Ratio
45.219
Quick Ratio
57.315
Current Ratio
57.315
Page 1
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Scribe Therapeutics, Inc. (SCTX)
Scribe Therapeutics, Inc. (SCTX)